2 RUNNING HEADER Abstract The article is proposed to provide a brief insight about the pathogen Escherichia coli, its classification and morphological characters, along with the suitable growth conditions and nutritional needs. It also discusses about the pathogenicity of the bacteria, along with the virulence factors and the type of disease it produces within the host. The symptoms, diagnosis and therapeutic intervention for the treatment of the disease is also explained in details. Article Summary E.coliis a gram-negative pathogenic bacteria which is found in the human intestine. The toxic and pathogenic strains of E,coli causes severe gastrointestinal problems such as diarrhea and urinary tract infection. It is a mesophile and can grow at moderate temperatures. It is a facultative anaerobe and can grow in absence of oxygen. It causes gastrointestinal problems in human as well as urinary tract infection. It is sensitive to quinolones and aminoglycosides, however some strains ofE.coliexhibit multi drug resistance. Pathogen Information Classification of microorganism EscherichiaColiis an unicellular, prokaryotic bacteria since it does not have a nucleus with a distinct nuclear membrane, nor does it have any specialized cellular organelles, instead it has a geneticmaterialcalled“nucleoid”.Itbelongstothegenus“Escherichia”andfamilyof “Enterobacteriaceae”. It is a gram negative, rod shaped bacteria. It does not produce spores, thus it is a non-spore forming microorganism, some of them contains peritrichous flagella for mobility while the others are non-motile, presence of fimbriae is also common in some strains. Few strains ofE.coliconsist of polysaccharide capsule, which increases its pathogenicity and also protects the bacteria from getting engulfed by macrophages, thus preventing phagocytosis. They are facultative anaerobes, which means that they are able to produce in presence or absence of oxygen through aerobic or anaerobic respiration respectively.
3 RUNNING HEADER Cellular/ structural (in case of viruses) characteristics. Escherichiacoliis a gram-negative rod shaped prokaryotic bacteria. The gram staining is a type of differential staining which helps in the differentiation between a gram-negative bacteria and gram negative. On gram staining, it takes up the gram-negative stain (saffranin) and appears reddish pink. Since it is a gram-negative rod, it has a very thin peptidoglycan layer. It mainly contains an outer layer consisting of phospholipids and polysaccharides, which gives a overall negative charge to the bacteria. As a result, it does not retain the Gram-positive crystal violet strain. Susceptibility to antibiotics/ antiviral or antifungals E.coliis found to be sensitive against antibiotics such as norfloxacin, ciprofloxacin, gentamicin and chloramphenicol. Ciprofloxacin and norfloxacin belongs to the class of Quinolone antibiotics, whereas, gentamicin belongs to the class of aminoglycoside antibiotics. The quinolones restricts bacterial growth by inhibiting replication of bacterial DNA by preventing the unwinding of the DNA through disruption of the action of DNA gyrase or Topoisomerase which induces a negative supercoiling of the DNA and thus relaxes the DNA. It is bactericidal in nature. The aminoglycosides are protein synthesis inhibitor which disrupts the synthesis of protein of the bacteria by binding to the 30S ribosomal subunit, inhibiting the translocation of peptidyl tRNA from the A-site to the P-site of the ribosomal subunit, thus leading to misreading of the genetic code. However, it is found thatE.coliis getting resistant to antibiotics by producing extended spectrum beta lactamase, which is an enzyme responsible for antibiotic ineffectivity and helping the bacteria to exhibit multi drug resistance. Growth conditions E.coli is a mesophile, which grows best around 20-370Celsius. It grows in a neutral pH environment. E.coli is also known as gut bacteria, as it resides inside the gut of the human body, where the temperature is around 370Celsius. It is a facultative anaerobe and is able to
4 RUNNING HEADER grow without the presence of oxygen through anaerobic respiration, however its growth rate is increased if oxygen is available. Evasion of immune system The E. coli strain O157:H7 causes infection by disrupting the immune system of the host(Wasey & Salen, 2019). These bacteria secretes a specific protein NIeH1 which alters the immune enzyme of the host. As a result, the bacterium evades the immune system of the host as well as extends their survival within the host, enabling the bacterium to persist and show its virulence and cause infection within the host. The virulence factors of the pathogenic strains of E.coli are: Endotoxins secreted from the LPS layer are responsible for inducing pathogenicity, polysaccharide capsule, which interferes with the antimicrobial activity, Fimbriae or pili, which helps in the attachment of the bacteria into the host surface, siderophores for the transport of iron molecules across cell membrane and lastly the drug resistant plasmids. Disease(s) caused Since, E.coli is present in the gastrointestinal tract of the humans, it is responsible for gastrointestinal problems such as traveler’s diarrhea(Cabal et al, 2016). It also causes UTI (Urinary Tract Infection), septicemia and other clinical infections such as meningitis or pneumonia. Symptoms The symptoms of traveler’s diarrhea are: Fever Nausea and Vomiting Abdominal bloating Abdominal cramp Malaise or weakness Frequent release of watery and profuse stools
Paraphrase This Document
Need a fresh take? Get an instant paraphrase of this document with our AI Paraphraser
5 RUNNING HEADER Diagnosis The diagnosis of Traveler’s diarrhea can be done by: Assessing the longevity of diarrhea whether it persist for more than 2 days Assess for abdominal pain or discomfort Check the frequency and urgency of passing of stool Check for any hyperactive bowel sensation Culturing of stool can be done to find the potential etiological organism Check the hydration status of the patient by assessing the skin turgor or moisture content of the mucous membrane Enquire the patient whether he has any food intolerance which may lead to increased peristalsis, or any tolerance to dairy products which may cause lactose intolerance which in turn increases the osmotic pressure and absorbs water into the intestinal lumen. Checking of the medical history of the patient, whether he had any past gastrointestinal problems or undergone any gastrointestinal surgery Therapeutic interventions The therapeutic interventions for treating Traveler’s diarrhea are: Prescription of anti-diarrheal drugs, which helps in the suppression of the gastrointestinal motility hence allowing better absorption of fluid Supplementation of probiotics, which reduces the gastrointestinal problems by re- establishing normal flora in the intestine Encourage patient to take more bulk fiber in the diet for better fluid absorption from stool and thickening of the stool; and avoid stimulants such as caffeine or beverage which may worsen diarrhea by increasing gastrointestinal motility Increase fluid intake, which helps to replace the fluid that is lost through diarrhea
6 RUNNING HEADER Encourage the patients to take meals in small amount and consume foods which are easy to digest.
7 RUNNING HEADER References Cabal, A., García-Castillo, M., Cantón, R., Gortázar, C., Domínguez, L., & Álvarez, J. (2016). Prevalence of Escherichia coli virulence genes in patients with diarrhea and a subpopulation of healthy volunteers in Madrid, Spain.Frontiers in microbiology,7, 641. Wasey, A., & Salen, P. (2019). Escherichia coli (E coli 0157 H7). InStatPearls [Internet]. StatPearls Publishing.